T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortinet
FTNT
|
+$2.03B |
| 2 |
Rockwell Automation
ROK
|
+$1.44B |
| 3 |
Autodesk
ADSK
|
+$1.15B |
| 4 |
Citigroup
C
|
+$975M |
| 5 |
ConocoPhillips
COP
|
+$967M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.59B |
| 2 |
GE Aerospace
GE
|
+$1.78B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.38B |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.08B |
| 5 |
Philip Morris
PM
|
+$1.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.21% |
| 2 | Healthcare | 15.42% |
| 3 | Financials | 10.99% |
| 4 | Consumer Discretionary | 10.39% |
| 5 | Communication Services | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
BJs Wholesale Club
BJ
$11.9B
| $26.7M | ﹤0.01% |
352,319
-50,907
| -13% | -$3.55M |
|
902
MGM Resorts International
MGM
$11.1B
| $26.6M | ﹤0.01% |
563,444
+5,968
| +1% | +$261K |
|
903
Prestige Consumer Healthcare
PBH
$2.43B
| $26.6M | ﹤0.01% |
366,159
-39,130
| -10% | -$2.62M |
|
904
Clorox
CLX
$12.9B
| $26.5M | ﹤0.01% |
172,767
-44,489
| -20% | -$6.64M |
|
905
Zai Lab
ZLAB
$2.92B
| $26.4M | ﹤0.01% |
1,650,787
-1,053,668
| -39% | -$22.2M |
|
906
Warner Bros
WBD
$69.6B
| $26.1M | ﹤0.01% |
2,990,840
+23,543
| +0.8% | +$227K |
|
907
Evertec
EVTC
$1.91B
| $26.1M | ﹤0.01% |
654,122
-734
| -0.1% | -$29K |
|
908
AMN Healthcare
AMN
$1.34B
| $26M | ﹤0.01% |
416,229
-96,158
| -19% | -$6.54M |
|
909
Principal Financial Group
PFG
$24.6B
| $26M | ﹤0.01% |
301,321
-3,129
| -1% | -$251K |
|
910
Jacobs Solutions
J
$16.8B
| $26M | ﹤0.01% |
204,148
+435
| +0.2% | +$51K |
|
911
Hilton Grand Vacations
HGV
$3.49B
| $25.9M | ﹤0.01% |
549,043
+755
| +0.1% | +$33K |
|
|
CHX
912
DELISTED
ChampionX
CHX
| $25.9M | ﹤0.01% |
720,438
-1,896,181
| -72% | -$56.7M |
|
|
PWSC
913
DELISTED
PowerSchool Holdings, Inc.
PWSC
| $25.9M | ﹤0.01% |
1,214,232
+62,870
| +5% | +$1.43M |
|
914
Masco
MAS
$14.7B
| $25.8M | ﹤0.01% |
327,086
-2,117
| -0.6% | -$153K |
|
915
Amphastar Pharmaceuticals
AMPH
$858M
| $25.7M | ﹤0.01% |
584,544
-2,413
| -0.4% | -$125K |
|
916
iRhythm Holdings
IRTC
$4.06B
| $25.6M | ﹤0.01% |
220,621
-171,833
| -44% | -$19.3M |
|
917
Ormat Technologies
ORA
$6.98B
| $25.5M | ﹤0.01% |
385,912
-16,399
| -4% | -$1.09M |
|
918
Hexcel
HXL
$7.74B
| $25.1M | ﹤0.01% |
344,342
+207,434
| +152% | +$14.9M |
|
919
Labcorp
LH
$26.2B
| $25M | ﹤0.01% |
114,488
+2,934
| +3% | +$646K |
|
|
EFOR
920
Everforth Inc
EFOR
$1.37B
| $25M | ﹤0.01% |
238,413
+21,625
| +10% | +$2.09M |
|
921
BridgeBio Pharma
BBIO
$15.9B
| $24.9M | ﹤0.01% |
803,956
+145,594
| +22% | +$4.95M |
|
922
Invesco
IVZ
$14.3B
| $24.8M | ﹤0.01% |
1,497,405
+58,332
| +4% | +$941K |
|
923
Kulicke & Soffa
KLIC
$5.01B
| $24.8M | ﹤0.01% |
492,350
-283,355
| -37% | -$14.2M |
|
924
Valvoline
VVV
$4.31B
| $24.7M | ﹤0.01% |
554,316
+34,467
| +7% | +$1.37M |
|
925
Rapid7
RPD
$929M
| $24.7M | ﹤0.01% |
503,468
+18,907
| +4% | +$1.04M |
|
Similar funds
T. Rowe Price Associates's Q1 2024 Portfolio in Review
As of Q1 2024, T. Rowe Price Associates held 3,021 positions worth $816B, up 9.6% from $744B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q1 2024 filing shows 108 new, 1,941 increased, 738 reduced and 64 closed positions. Its largest new stake was GE Vernova: 2,687,194 shares worth $367M. The largest sale was NVIDIA, an estimated $2.59B.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q1 2024 buy was GE Vernova: 2,687,194 shares worth $367M.
- T. Rowe Price Associates added most to Fortinet in Q1 2024, an estimated $2.03B increase.
- T. Rowe Price Associates's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $2.59B.
- T. Rowe Price Associates fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $621M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $816B portfolio in Q1 2024.
- T. Rowe Price Associates opened 108 new positions and closed 64 in Q1 2024.
- T. Rowe Price Associates's portfolio value rose 9.6% quarter-over-quarter to $816B.
Based on T. Rowe Price Associates's 13F filing for Q1 2024, filed 15 May 2024.